AI in Oncology for Analytical Solutions Market Report 2026

The ai in oncology for analytical solutions market size has grown exponentially in recent years. It will grow from $1.44 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 34.2%. The growth in the historic period can be attributed to limited ai adoption in oncology, reliance on conventional diagnostic methods, growing cancer prevalence globally, increasing clinical research activities, rising demand for personalized medicine.

The ai in oncology for analytical solutions market size is expected to see exponential growth in the next few years. It will grow to $6.26 billion in 2030 at a compound annual growth rate (CAGR) of 34.2%. The growth in the forecast period can be attributed to advancements in ai algorithms for oncology, expansion of oncology data licensing services, increasing integration of ai with genomic data, rising adoption of clinical decision support software, growing collaboration between healthcare providers and ai solution vendors. Major trends in the forecast period include increasing adoption of AI-based imaging and diagnostic software, rising use of predictive analytics in oncology research, expansion of clinical decision support systems for treatment planning, growing integration of genomic data with cancer treatment solutions, increasing demand for data licensing and analytics services.

The growing incidence of cancer is anticipated to drive the expansion of the AI in oncology for analytical solutions market in the coming years. Cancer is defined as a group of diseases marked by the uncontrolled growth and spread of abnormal cells. AI in oncology analytical solutions supports cancer care by enabling personalized treatment approaches, early diagnosis, and improved patient outcomes, leveraging its capability to rapidly and efficiently analyze large volumes of complex data. For instance, in May 2024, the National Cancer Institute, a U.S.-based government agency, reported that nearly 2 million new cancer cases are projected to be diagnosed in the United States in 2024, with more than 611,000 deaths expected. Globally, new cancer cases are forecast to reach 29.9 million by 2040, while cancer-related deaths are projected to rise to 15.3 million. Therefore, the increasing prevalence of cancer is fueling the growth of the AI in oncology for analytical solutions market.

Major companies operating in the AI in oncology for analytical solutions market are concentrating on advancing AI technologies, including the development of new real-world data platforms to accelerate cancer research and enhance generative AI models in oncology. A real-world data platform is a system designed to integrate and manage observational data from diverse sources beyond traditional clinical trial environments, such as electronic health records, insurance claims, patient-reported data, and disease registries. For instance, in October 2023, the Central Ohio Transit Authority, a U.S.-based company, introduced Vista, a real-world data platform developed to accelerate cancer research and improve generative AI applications in oncology. The platform aims to deliver a more comprehensive and standardized approach to cancer data management by integrating multiple databases, including data portal and genomic databases. Additionally, Vista is expected to enable better data sharing, enhance data quality, and support a wide range of applications within oncology and broader healthcare settings.

In December 2023, ConcertAI, an India-based medical research developer, acquired CancerLinQ for an undisclosed amount. This acquisition is intended to establish a leading healthcare learning and research network in oncology while offering members enhanced quality reporting, industry-leading real-world data, and AI-powered tools to accelerate clinical trials. CancerLinQ is a U.S.-based cancer treatment organization that provides AI-driven data and analytics solutions.

Major companies operating in the ai in oncology for analytical solutions market are IBM Watson Health, NVIDIA Corporation, Siemens Healthineers, GE Healthcare, Tempus, DeepMind Health, Paige.AI, PathAI, Aidoc, Nucleai, OWKIN, SOPHiA Genetics, Imagen Technologies, Atomwise, Enlitic, Inspirata, 3Scan, Zebra Medical Vision, Ibex Medical Analytics, Vuno Inc., Proscia, Google Health, Huiying Medical.

North America was the largest region in the AI In oncology for analytical solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ai in oncology for analytical solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ai in oncology for analytical solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the AI in oncology for analytical solutions market by increasing costs of imported software solutions, analytics platforms, and data licensing services. Segments such as AI-based imaging software, predictive analytics services, and clinical decision support software are most affected, particularly in North America, Europe, and Asia-Pacific regions with significant AI healthcare adoption. While tariffs raise operational costs and slow procurement, they also encourage local software development, investment in domestic AI platforms, and innovation in analytics services.

The ai in oncology for analytical solutions market research report is one of a series of new reports that provides ai in oncology for analytical solutions market statistics, including ai in oncology for analytical solutions industry global market size, regional shares, competitors with a ai in oncology for analytical solutions market share, detailed ai in oncology for analytical solutions market segments, market trends and opportunities, and any further data you may need to thrive in the ai in oncology for analytical solutions industry. This ai in oncology for analytical solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI in oncology for analytical solutions involves the application of artificial intelligence technologies within the oncology field to create advanced analytical tools for cancer research, diagnosis, and treatment. These solutions enable healthcare professionals to make informed, data-driven decisions, enhance diagnostic precision, and customize treatment strategies.

The key components of AI in oncology analytical solutions include data licensing services, software solutions, analytics, and others. Data licensing involves granting or acquiring authorized access to data through formal agreements between data providers and users. These solutions support various treatment approaches such as chemotherapy, radiotherapy, immunotherapy, and other therapies. They are applied across multiple cancer types, including breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumors, kidney cancer, non-Hodgkin lymphoma, and bladder cancer.

The AI in oncology for analytical solutions market consists of revenues earned by entities by providing services such as consulting services, implementation services, training services, medical imaging analysis services, genomic data interpretation services, and drug discovery and development solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in oncology for analytical solutions market also includes sales of AI-powered imaging tools, drug discovery and development devices, and recurrence monitoring systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.